Comparison of outcomes of second-line durvalumab plus tremelimumab versus lenvatinib following first-line atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.
Saved in:
| Title: | Comparison of outcomes of second-line durvalumab plus tremelimumab versus lenvatinib following first-line atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. |
|---|---|
| Authors: | Nishioka, Chinatsu1 (AUTHOR), Tahata, Yuki1 (AUTHOR), Maesaka, Kazuki1 (AUTHOR), Kai, Machiko1 (AUTHOR), Shirai, Kumiko1 (AUTHOR), Murai, Kazuhiro1 (AUTHOR), Makino, Yuki1 (AUTHOR), Saito, Yoshinobu1 (AUTHOR), Nozaki, Yasutoshi2 (AUTHOR), Nakabori, Tasuku3 (AUTHOR), Ishida, Hisashi4 (AUTHOR), Yakushijin, Takayuki5 (AUTHOR), Iio, Sadaharu6 (AUTHOR), Tatsumi, Nobuyuki7 (AUTHOR), Imanaka, Kazuho8 (AUTHOR), Kakita, Naruyasu9 (AUTHOR), Sakamori, Ryotaro10 (AUTHOR), Hosui, Atsushi11 (AUTHOR), Miyazaki, Masanori12 (AUTHOR), Matsumoto, Kengo13 (AUTHOR) |
| Source: | PLoS ONE. 5/7/2026, Vol. 21 Issue 5, p1-14. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 193596886 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Comparison of outcomes of second-line durvalumab plus tremelimumab versus lenvatinib following first-line atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Nishioka%2C+Chinatsu%22">Nishioka, Chinatsu</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tahata%2C+Yuki%22">Tahata, Yuki</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Maesaka%2C+Kazuki%22">Maesaka, Kazuki</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kai%2C+Machiko%22">Kai, Machiko</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shirai%2C+Kumiko%22">Shirai, Kumiko</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Murai%2C+Kazuhiro%22">Murai, Kazuhiro</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Makino%2C+Yuki%22">Makino, Yuki</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Saito%2C+Yoshinobu%22">Saito, Yoshinobu</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nozaki%2C+Yasutoshi%22">Nozaki, Yasutoshi</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nakabori%2C+Tasuku%22">Nakabori, Tasuku</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ishida%2C+Hisashi%22">Ishida, Hisashi</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yakushijin%2C+Takayuki%22">Yakushijin, Takayuki</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Iio%2C+Sadaharu%22">Iio, Sadaharu</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tatsumi%2C+Nobuyuki%22">Tatsumi, Nobuyuki</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Imanaka%2C+Kazuho%22">Imanaka, Kazuho</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kakita%2C+Naruyasu%22">Kakita, Naruyasu</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sakamori%2C+Ryotaro%22">Sakamori, Ryotaro</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hosui%2C+Atsushi%22">Hosui, Atsushi</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Miyazaki%2C+Masanori%22">Miyazaki, Masanori</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Matsumoto%2C+Kengo%22">Matsumoto, Kengo</searchLink><relatesTo>13</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22PLoS+ONE%22">PLoS ONE</searchLink>. 5/7/2026, Vol. 21 Issue 5, p1-14. 14p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=193596886 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pone.0341395 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 14 StartPage: 1 Titles: – TitleFull: Comparison of outcomes of second-line durvalumab plus tremelimumab versus lenvatinib following first-line atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Nishioka, Chinatsu – PersonEntity: Name: NameFull: Tahata, Yuki – PersonEntity: Name: NameFull: Maesaka, Kazuki – PersonEntity: Name: NameFull: Kai, Machiko – PersonEntity: Name: NameFull: Shirai, Kumiko – PersonEntity: Name: NameFull: Murai, Kazuhiro – PersonEntity: Name: NameFull: Makino, Yuki – PersonEntity: Name: NameFull: Saito, Yoshinobu – PersonEntity: Name: NameFull: Nozaki, Yasutoshi – PersonEntity: Name: NameFull: Nakabori, Tasuku – PersonEntity: Name: NameFull: Ishida, Hisashi – PersonEntity: Name: NameFull: Yakushijin, Takayuki – PersonEntity: Name: NameFull: Iio, Sadaharu – PersonEntity: Name: NameFull: Tatsumi, Nobuyuki – PersonEntity: Name: NameFull: Imanaka, Kazuho – PersonEntity: Name: NameFull: Kakita, Naruyasu – PersonEntity: Name: NameFull: Sakamori, Ryotaro – PersonEntity: Name: NameFull: Hosui, Atsushi – PersonEntity: Name: NameFull: Miyazaki, Masanori – PersonEntity: Name: NameFull: Matsumoto, Kengo IsPartOfRelationships: – BibEntity: Dates: – D: 07 M: 05 Text: 5/7/2026 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 19326203 Numbering: – Type: volume Value: 21 – Type: issue Value: 5 Titles: – TitleFull: PLoS ONE Type: main |
| ResultId | 1 |